drugset / Trial / NCT00656188

Placebo-controlled Study Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction

NCT00656188

Phase 2/3 Completed 463 enrolled Bayer GlaxoSmithKline · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This study tested the hypothesis that vardenafil was both clinically effective and well-tolerated compared to placebo in men diagnosed as being unresponsive to sildenafil.

Timeline

Start
2002-10
Primary completion
2003-05
Completion
2003-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Vardenafil Small molecule 5 mg Oral
Comparator Vardenafil Small molecule 10 mg Oral
Comparator Vardenafil Small molecule 20 mg Oral

Indications